Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 124

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 124
---
 or the notes thereto.

| Item 9. | Undertakings |

| (a) | The undersigned Registrant hereby undertakes: |

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this 
 registration statement:                                                                                |

| (i) | to include any prospectus required by section 10(a)(3) of the Securities Act; |

| (ii) | to reflect in the prospectus any facts or events arising after the effective date of the registration                                       
 statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change     
 in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities 
 offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or      
 high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule      
 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price    
 set forth in the “Calculation of Registration Fee” table in the effective registration statement; and                                       |

| (iii) | to include any material information with respect to the plan of distribution not previously disclosed   
 in the registration statement or any material change to such information in the registration statement; |

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective                                        
 amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities 
 at that time shall be deemed to be the initial bona fide offering thereof.                                                                   |

| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered 
 which remain unsold at the termination of the offering.                                                   |

| II-2 |

| (4) | To file a post-effective amendment to the registration statement to include any financial statements required                             
 by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information  
 otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the                     
 prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and